ナイアシンアミド市場：形態、生産、グレード、用途別-2025-2030年の世界予測

ナイアシンアミド市場は2023年に7億1,577万米ドルと評価され、2024年には7億4,560万米ドルに達すると予測され、CAGR 4.65%で成長し、2030年には9億8,411万米ドルに達すると予測されています。

ビタミンB3の一種であるナイアシンアミドは、スキンケア効果が広く認められている多面的な成分であり、化粧品やパーソナルケア産業に大きな付加価値を与えています。その必要性は、抗炎症作用、抗老化作用、美白作用から生じ、多機能なスキンケアソリューションを求める消費者にアピールしています。ナイアシンアミドは、ニキビ、色素沈着、肌の保湿をターゲットとしたクリーム、美容液、ローションに応用されています。最終用途の範囲はスキンケアにとどまらず、神経系や消化器系への有益な影響から栄養補助食品や医薬品にも及ぶ。

市場成長の主な原動力は、スキンケアとウェルネスに対する消費者の意識の高まり、天然で汎用性の高い成分への需要の高まり、皮膚疾患の有病率の上昇です。急成長する美容・パーソナルケア業界は、オーガニックで持続可能な製品への強い傾倒があり、市場拡大の起爆剤となっています。さらに、多様な製品ラインにナイアシンアミドが統合されることで、プレミアムブランドから大衆向け製品まで、複数のエントリーポイントとユーザー層が育まれます。

有望な見通しとは裏腹に、市場成長は、化粧品処方を取り巻く厳しい規制や、ユーザーの潜在的な皮膚過敏性問題などの課題に直面しています。また、ヒアルロン酸やビタミンCなどの代替成分による競合圧力も、限界をもたらしています。

市場機会を活用するために、企業はナイアシンアミドと補完的な成分を組み合わせた革新的な製剤に注力し、製品の有効性と消費者の満足度を最適化する必要があります。ヘアケアやネイルケアへの広範な応用を探る調査に投資することで、さらなる市場スペースが開けるかもしれないです。特に消費者の環境意識が高まる中、製品の調達と生産プロセスにおける透明性と持続可能性を強調することで、ブランドの信頼と魅力を高めることができます。市場はダイナミックで競争が激しく、技術革新は主に製品供給方法の進歩や処方の改良を反映しています。消費者の嗜好の変化に対応し、スキンケア効能試験の技術的進歩を活用することで、企業はこの活気ある市場空間で独自の地位を築くことができます。

市場力学：急速に進化するナイアシンアミド市場の主要市場インサイトを公開

ナイアシンアミド市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病、変形性関節症、高リン血症に対するナイアシンアミド含有食品またはサプリメントに対する消費者の需要
  • ナイアシンアミドを含むスキンケア製品に対する需要の高まり
  • 飼料強化のためのナイアシンアミド使用の増加
• 市場抑制要因
  • 原料の入手可能性の制限と価格の不安定性
• 市場機会
  • がん治療のためのナイアシンアミド治療法開発のための広範な研究開発活動
  • 一般用医薬品（OTC）への嗜好の高まり
• 市場の課題
  • ナイアシンアミドの長期使用に伴う副作用やアレルギー反応

ポーターの5つの力：ナイアシンアミド市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ナイアシンアミド市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ナイアシンアミド市場における外部からの影響の把握

外部マクロ環境要因は、ナイアシンアミド市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ナイアシンアミド市場における競合情勢の把握

ナイアシンアミド市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスナイアシンアミド市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ナイアシンアミド市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ナイアシンアミド市場における成功への道筋を描く

ナイアシンアミド市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病、変形性関節症、高リン血症に対するナイアシンアミド含有食品やサプリメントに対する消費者の需要
    • ナイアシンアミドを含むスキンケア製品の需要増加
    • 動物飼料の強化におけるナイアシンアミドの使用増加
  • 抑制要因
    • 原材料の入手の制限と価格の変動
  • 機会
    • がん治療のためのナイアシンアミド治療法の開発に向けた広範な研究開発活動
    • 市販の化粧品への嗜好の高まり
  • 課題
    • ナイアシンアミドの長期使用に伴う副作用およびアレルギー反応
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ナイアシンアミド市場：形態別

• 粒状
• 液体
• 粉

第7章 ナイアシンアミド市場制作者

• 天然
• 合成

第8章 ナイアシンアミド市場：グレード別

• 飼料グレード
• 医薬品グレード

第9章 ナイアシンアミド市場：用途別

• 動物栄養
• 化粧品
• 人間の栄養
• 医薬品

第10章 南北アメリカのナイアシンアミド市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のナイアシンアミド市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのナイアシンアミド市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AIE Pharmaceuticals, Inc.
• Bio-Tech Pharmacal, Inc.
• Evonik Industries AG
• Fagron Inc.
• Foodchem International Corporation
• Gemini Pharmaceuticals
• Glanbia PLC
• Koninklijke DSM N.V.
• Lasons India Pvt Ltd.
• Lonza Group AG
• Merck KGaA
• NutraScience Labs
• Spectrum Chemical Mfg. Corporation
• Vertellus LLC
• Western Drugs Ltd.
• Yuki Gosei Kogyo Co., Ltd.

LIST OF FIGURES

• FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
• FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NIACINAMIDE MARKET DYNAMICS
• TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY HUMAN NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. CHINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 62. INDIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. ITALY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. POLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 147. POLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 151. QATAR NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

The Niacinamide Market was valued at USD 715.77 million in 2023, expected to reach USD 745.60 million in 2024, and is projected to grow at a CAGR of 4.65%, to USD 984.11 million by 2030.

Niacinamide, a form of vitamin B3, is a multifaceted ingredient widely recognized for its skincare benefits, adding significant value to the cosmetics and personal care industries. Its necessity arises from its anti-inflammatory, anti-aging, and brightening properties, appealing to consumers seeking multifunctional skincare solutions. Niacinamide finds applications in creams, serums, and lotions targeting acne, hyperpigmentation, and skin hydration. The end-use scope extends beyond skincare, encompassing dietary supplements and pharmaceutical products due to its beneficial impacts on the nervous and digestive systems.

Market growth is primarily driven by increasing consumer awareness of skincare and wellness, escalating demand for natural and versatile ingredients, and the rising prevalence of skin disorders. The burgeoning beauty and personal care industry, with a strong inclination towards organic and sustainable products, catalyzes the market expansion. Furthermore, the integration of niacinamide in diverse product lines fosters multiple entry points and user segments, from premium brands to mass-market offerings.

Despite its promising outlook, market growth faces challenges, including stringent regulations surrounding cosmetic formulations and potential skin sensitivity issues among users. Competitive pressures from alternative ingredients, such as hyaluronic acid and vitamin C, also pose limitations.

To capitalize on market opportunities, companies should focus on innovative formulations that combine niacinamide with complementary ingredients, ensuring optimal product efficacy and consumer satisfaction. Investing in research that explores its broader applications in hair and nail care could unlock additional market spaces. Emphasizing transparency and sustainability in product sourcing and production processes can enhance brand trust and appeal, especially amid increasing consumer environmental consciousness. The market is dynamic and highly competitive, with innovation predominantly reflecting advancements in product delivery methods and enhanced formulations. By staying attuned to evolving consumer preferences and leveraging technological advancements in skincare efficacy testing, businesses can carve out a unique position in this vibrant market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Niacinamide Market

The Niacinamide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
  • Increasing demand for skin care products containing niacinamide
  • Growing use of niacinamide for animal feed fortification
• Market Restraints
  • Limited availability and volatility of the prices of ingredients
• Market Opportunities
  • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
  • Growing preference for Over-the-counter (OTC) cosmeceuticals
• Market Challenges
  • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Porter's Five Forces: A Strategic Tool for Navigating the Niacinamide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Niacinamide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Niacinamide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Niacinamide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Niacinamide Market

A detailed market share analysis in the Niacinamide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Niacinamide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Niacinamide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Niacinamide Market

A strategic analysis of the Niacinamide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Form, market is studied across Granular, Liquid, and Powder.
• Based on Production, market is studied across Natural and Synthetic.
• Based on Grade, market is studied across Feed Grade and Pharmaceutical Grade.
• Based on Application, market is studied across Animal Nutrition, Cosmeceuticals, Human Nutrition, and Pharmaceuticals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • 5.1.1.2. Increasing demand for skin care products containing niacinamide
    • 5.1.1.3. Growing use of niacinamide for animal feed fortification
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and volatility of the prices of ingredients
  • 5.1.3. Opportunities
    • 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Niacinamide Market, by Form

• 6.1. Introduction
• 6.2. Granular
• 6.3. Liquid
• 6.4. Powder

7. Niacinamide Market, by Production

• 7.1. Introduction
• 7.2. Natural
• 7.3. Synthetic

8. Niacinamide Market, by Grade

• 8.1. Introduction
• 8.2. Feed Grade
• 8.3. Pharmaceutical Grade

9. Niacinamide Market, by Application

• 9.1. Introduction
• 9.2. Animal Nutrition
• 9.3. Cosmeceuticals
• 9.4. Human Nutrition
• 9.5. Pharmaceuticals

10. Americas Niacinamide Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Niacinamide Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Niacinamide Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AIE Pharmaceuticals, Inc.
• 2. Bio-Tech Pharmacal, Inc.
• 3. Evonik Industries AG
• 4. Fagron Inc.
• 5. Foodchem International Corporation
• 6. Gemini Pharmaceuticals
• 7. Glanbia PLC
• 8. Koninklijke DSM N.V.
• 9. Lasons India Pvt Ltd.
• 10. Lonza Group AG
• 11. Merck KGaA
• 12. NutraScience Labs
• 13. Spectrum Chemical Mfg. Corporation
• 14. Vertellus LLC
• 15. Western Drugs Ltd.
• 16. Yuki Gosei Kogyo Co., Ltd.